MHRA-licensed vitamin D drug launched in UK
The first MHRA-licensed treatment for vitamin D deficiency in young children, pregnant women and breastfeeding mothers has been launched in the UK by Internis Pharamceuticals.
Read MoreAuthor: George Underwood
£10bn fund could boost UK pharma investment
A £10 billion ‘megafund’ to help UK pharma firms develop new drugs will be discussed at a conference held by the mayor of London’s office today.
Read MorePublic prioritises care for the elderly and 7-day GPs
A new YouGov poll suggests that the UK public views care for the elderly and weekend access to GPs as the top priorities for the NHS.
Read MoreGSK sells meningitis vaccines to Pfizer
GlaxoSmithKline will sell its meningitis vaccines Nimenrix and Mencevax to Pfizer to satisfy regulatory conditions for its asset-swap deal with Novartis.
Read MoreTeva buys more Mylan shares as takeover fight continues
Teva has raised its stake in Mylan to 4.61%, which will allow it to take its acquisition bid to court “should it become necessary”.
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
